Related Experiment Video

Updated: Jul 30, 2026

Quantitative Analysis of Cancer Metastasis using an Avian Embryo Model
08:40

Quantitative Analysis of Cancer Metastasis using an Avian Embryo Model

Published on: May 30, 2011

Comment on "The process of metastasisation for breast cancer" by J. Engel, R. Eckel, J. Kerr et al

R Demicheli, M W Retsky

    European Journal of Cancer (Oxford, England : 1990)
    |February 14, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
    09:44

    Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

    Published on: June 13, 2016

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
    07:35

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

    Published on: December 26, 2016

    Related Experiment Videos

    Last Updated: Jul 30, 2026

    Quantitative Analysis of Cancer Metastasis using an Avian Embryo Model
    08:40

    Quantitative Analysis of Cancer Metastasis using an Avian Embryo Model

    Published on: May 30, 2011

    Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
    09:44

    Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

    Published on: June 13, 2016

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
    07:35

    A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

    Published on: December 26, 2016

    Related Concept Videos

    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    Metastasis02:30

    Metastasis

    Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
    Epithelial-to-Mesenchymal Transition
    The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

    Articles linked to this work by shared authors, journal, and citation graph.

    Tocilizumab and immune signatures for targeted management of cytokine release syndrome in immune checkpoint therapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024

    Is there a rationale for an anesthesiologist's role against cancer recurrence?

    Acta anaesthesiologica Belgica·2013

    Gene regulatory networks: a new conceptual framework to analyse breast cancer behaviour.

    Annals of oncology : official journal of the European Society for Medical Oncology·2010

    Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer.

    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2008

    The effects of surgery on tumor growth: a century of investigations.

    Annals of oncology : official journal of the European Society for Medical Oncology·2008

    Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.

    Annals of oncology : official journal of the European Society for Medical Oncology·2005

    Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe.

    European journal of cancer (Oxford, England : 1990)·2026

    Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.

    European journal of cancer (Oxford, England : 1990)·2026

    Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.

    European journal of cancer (Oxford, England : 1990)·2026

    Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.

    European journal of cancer (Oxford, England : 1990)·2026

    Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.

    European journal of cancer (Oxford, England : 1990)·2026

    Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.

    European journal of cancer (Oxford, England : 1990)·2026

    Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral.

    JACC. CardioOncology·2026

    Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial.

    Crohn's & colitis 360·2026

    Unrecognized Charcot-Marie-Tooth Disease Unmasked by Chemotherapy-Induced Neurotoxicity.

    Cureus·2026

    Intraoperative Hemodynamic Management and Cerebral Protection During Awake Craniotomy: Evidence-Based Approaches.

    Anesthesiology research and practice·2026

    Combined Enzyme-Responsive Nano-Peptide Drug with Photothermal Function for Effective Anti-Hepatocellular Carcinoma in Mice Model.

    International journal of nanomedicine·2026

    Pathologic Complete Response to Neoadjuvant Dual Checkpoint Blockade with Durvalumab Plus Tremelimumab in Advanced-Stage HCC: A Case Report.

    Journal of hepatocellular carcinoma·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us